OVERSEA CHINESE BANKING Corp Ltd Buys Shares of 21,673 Astera Labs, Inc. $ALAB

OVERSEA CHINESE BANKING Corp Ltd bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 21,673 shares of the company’s stock, valued at approximately $3,605,000.

Several other institutional investors have also recently added to or reduced their stakes in ALAB. Assetmark Inc. increased its stake in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the last quarter. Hilltop National Bank increased its stake in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares during the last quarter. Aventura Private Wealth LLC bought a new stake in Astera Labs during the fourth quarter valued at $33,000. National Bank of Canada FI increased its stake in Astera Labs by 159.0% during the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares during the last quarter. Finally, Wexford Capital LP bought a new stake in Astera Labs during the third quarter valued at $39,000. Institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on ALAB shares. UBS Group started coverage on shares of Astera Labs in a research note on Tuesday. They set a “neutral” rating and a $180.00 target price for the company. Citigroup started coverage on shares of Astera Labs in a research note on Thursday, April 2nd. They set a “buy” rating and a $200.00 target price for the company. Royal Bank Of Canada restated an “outperform” rating and set a $250.00 price target on shares of Astera Labs in a research report on Tuesday. Loop Capital started coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target for the company. Finally, Barclays set a $165.00 price target on shares of Astera Labs in a research report on Thursday, January 15th. Fifteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $199.74.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Big cloud/hyperscaler deal tailwinds — analysts link Amazon/Anthropic’s $100B build?out to follow?on orders for connectivity silicon like Astera’s, underpinning multi?year revenue upside. Read More.
• Positive Sentiment: Product demand and earnings momentum — coverage highlights surging Aries and Taurus demand and strong fundamentals (Q4 revenue +91.8%, EPS beat, Q1 guidance), supporting further upside as AI data?center builds continue. Read More.
• Positive Sentiment: Analyst price?target lift amplified buying — recent upgrades (including RBC’s $250 PT) triggered a sharp intraday rally and heavier volume as momentum traders piled in. Read More.
• Neutral Sentiment: UBS starts coverage at “neutral” with a $180 target — a formal coverage initiation that limits near?term runway implied by some bulls (PT ~7% below the latest price). Read More.
• Neutral Sentiment: Momentum and hedge?fund attention — technical buy signals and hedge?fund interest can magnify moves (higher intraday volatility) but don’t change underlying fundamentals. Read More.
• Negative Sentiment: Significant insider selling — CEO and a director executed large Rule 10b5?1 sales this month (including a multi?million?dollar block), which investors may view as supply pressure despite being planned trades. Read More.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares of the company’s stock, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 94,971 shares of the company’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the sale, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at $189,590,376.81. The trade was a 5.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 1,064,888 shares of company stock valued at $150,764,723. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Stock Performance

Astera Labs stock opened at $194.06 on Thursday. The company has a 50-day simple moving average of $130.79 and a 200-day simple moving average of $153.77. The firm has a market capitalization of $33.23 billion, a P/E ratio of 159.07, a P/E/G ratio of 3.78 and a beta of 1.78. Astera Labs, Inc. has a one year low of $59.32 and a one year high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company’s quarterly revenue was up 91.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 1.48 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.